Suchergebnisse - "Takami, Taro"

PubPharm (235)

1

Multicenter Prospective Cohort Study of Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer (YPB-001)

enthalten in: Pancreas | 2024

von Matsui, H. | Ioka, T. | Takahashi, T. | +15

2

Kaposi's Sarcoma of the Stomach

enthalten in: Internal medicine (Tokyo, Japan) | 2024

von Goto, A. | Hashimoto, S. | Nakamura, K. | +1

3

Portopulmonary Hypertension Treated by Occlusion of a Spontaneous Portosystemic Shunt Followed by Endothelin Receptor Antagonist Administration

enthalten in: Journal of vascular and interventional radiology : JVIR | 2024

von Ishikawa, T. | Kawamoto, D. | Nishimura, T. | +3

4

Varying impact of lenvatinib or sorafenib therapy on skeletal muscle loss in patients with hepatocellular carcinoma

enthalten in: Oncology | 2024

von Yamauchi, Y. | Saeki, I. | Fujisawa, K. | +12

5

Treatment of Inflammatory Bowel Disease with Biologics in Japan : A Single-Center, Retrospective Pharmacoeconomic Study

enthalten in: Biological & pharmaceutical bulletin | 2024

von Saisyo, A. | Hashimoto, S. | Ishida, H. | +8

6

Traction Method Using Multiloop Traction Device for Duodenal Tumor With Scarring

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2023

von Yamamoto, K. | Goto, A. | Takami, T.

7

Posttreatment liver function, but not baseline liver function stratifies patient survival after direct-acting antiviral treatment in decompensated cirrhosis with hepatitis C virus

enthalten in: Journal of gastroenterology | 2023

von Tahata, Y. | Hikita, H. | Mochida, S. | +35

8

Retraction Note : Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox

enthalten in: BMC cancer | 2023

von Amano, S. | Kaino, S. | Shinoda, S. | +7

RetractionOf: BMC Cancer. 2020 Jul 22;20(1):681. - PMID 32698792

9

METHOD FOR EVALUATING MESENCHYMAL STEM CELL ACTIVITY, METHOD FOR CULTURING MESENCHYMAL STEM CELLS, METHOD FOR PRODUCING THERAPEUTIC AGENT FOR LIVER DYSFUNCTION, AND THERAPEUTIC AGENT FOR LIVER DYSFUNCTION

enthalten in: Europäisches Patentamt | 2023

von SAKAIDA ISAO | TERAI SHUJI | TAKAMI TARO | +3

10

Lysosomal cholesterol overload in macrophages promotes liver fibrosis in a mouse model of NASH

enthalten in: The Journal of experimental medicine | 2023

von Itoh, M. | Tamura, A. | Kanai, S. | +17

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[24]